Price (delayed)
$0.22
Market cap
$8.31M
P/E Ratio
1.05
Dividend/share
N/A
EPS
$0.21
Enterprise value
$208,162
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Its protease engineering platform has generated
There are no recent dividends present for CBIO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.